The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Embecta Corp. (“Embecta” or the “Company”) (NASDAQ: EMBC) common stock between November 25, 2025 and May 4, 2026, inclusive (the “Class Period”). Embecta investors have until August 17, 2026 to file a lead plaintiff motion.

What Happened?

On May 5, 2026, Embecta released its second quarter fiscal 2026 financial results, revealing that revenue had declined over 14%, largely due to weakness in its pen needle sales. Additionally, the Company lowered its guidance for the remainder of fiscal 2026.

On this news, Embecta’s stock price fell $5.35, or 57.8%, to close at $3.90 per share on May 5, 2026, thereby injuring investors.

What Is The Lawsuit About?

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the Company’s guidance was misleading and unattainable; (2) segment weakness, especially in the United States pen needle market, was likely to disrupt the Company’s original revenue guidance and second quarter 2026 results; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.